BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19318631)

  • 1. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
    Migita T; Ruiz S; Fornari A; Fiorentino M; Priolo C; Zadra G; Inazuka F; Grisanzio C; Palescandolo E; Shin E; Fiore C; Xie W; Kung AL; Febbo PG; Subramanian A; Mucci L; Ma J; Signoretti S; Stampfer M; Hahn WC; Finn S; Loda M
    J Natl Cancer Inst; 2009 Apr; 101(7):519-32. PubMed ID: 19318631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
    Yoshii Y; Furukawa T; Oyama N; Hasegawa Y; Kiyono Y; Nishii R; Waki A; Tsuji AB; Sogawa C; Wakizaka H; Fukumura T; Yoshii H; Fujibayashi Y; Lewis JS; Saga T
    PLoS One; 2013; 8(5):e64570. PubMed ID: 23741342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer.
    Fiorentino M; Zadra G; Palescandolo E; Fedele G; Bailey D; Fiore C; Nguyen PL; Migita T; Zamponi R; Di Vizio D; Priolo C; Sharma C; Xie W; Hemler ME; Mucci L; Giovannucci E; Finn S; Loda M
    Lab Invest; 2008 Dec; 88(12):1340-8. PubMed ID: 18838960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
    Wen S; Niu Y; Lee SO; Yeh S; Shang Z; Gao H; Li Y; Chou F; Chang C
    Mol Carcinog; 2016 Dec; 55(12):2278-2290. PubMed ID: 26894509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring a role for fatty acid synthase in prostate cancer cell migration.
    De Piano M; Manuelli V; Zadra G; Loda M; Muir G; Chandra A; Morris J; Van Hemelrijck M; Wells CM
    Small GTPases; 2021 Jul; 12(4):265-272. PubMed ID: 33043786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
    Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
    PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma.
    Shah US; Dhir R; Gollin SM; Chandran UR; Lewis D; Acquafondata M; Pflug BR
    Hum Pathol; 2006 Apr; 37(4):401-9. PubMed ID: 16564913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.
    Sun T; Zhong X; Song H; Liu J; Li J; Leung F; Lu WW; Liu ZL
    Cell Death Dis; 2019 Apr; 10(4):298. PubMed ID: 30931932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatty acid synthase in the diagnosis of prostate neoplasms].
    Allina DO; Andreeva YY; Zavalishina LE; Moskvina LV; Frank GA
    Arkh Patol; 2017; 79(2):10-14. PubMed ID: 28418352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
    Nick AM; Stone RL; Armaiz-Pena G; Ozpolat B; Tekedereli I; Graybill WS; Landen CN; Villares G; Vivas-Mejia P; Bottsford-Miller J; Kim HS; Lee JS; Kim SM; Baggerly KA; Ram PT; Deavers MT; Coleman RL; Lopez-Berestein G; Sood AK
    J Natl Cancer Inst; 2011 Nov; 103(21):1596-612. PubMed ID: 21957230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
    Zadra G; Ribeiro CF; Chetta P; Ho Y; Cacciatore S; Gao X; Syamala S; Bango C; Photopoulos C; Huang Y; Tyekucheva S; Bastos DC; Tchaicha J; Lawney B; Uo T; D'Anello L; Csibi A; Kalekar R; Larimer B; Ellis L; Butler LM; Morrissey C; McGovern K; Palombella VJ; Kutok JL; Mahmood U; Bosari S; Adams J; Peluso S; Dehm SM; Plymate SR; Loda M
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):631-640. PubMed ID: 30578319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss.
    Bastos DC; Ribeiro CF; Ahearn T; Nascimento J; Pakula H; Clohessy J; Mucci L; Roberts T; Zanata SM; Zadra G; Loda M
    J Pathol; 2021 Mar; 253(3):292-303. PubMed ID: 33166087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
    Li L; Pilo GM; Li X; Cigliano A; Latte G; Che L; Joseph C; Mela M; Wang C; Jiang L; Ribback S; Simile MM; Pascale RM; Dombrowski F; Evert M; Semenkovich CF; Chen X; Calvisi DF
    J Hepatol; 2016 Feb; 64(2):333-341. PubMed ID: 26476289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells.
    Andriani F; Nan B; Yu J; Li X; Weigel NL; McPhaul MJ; Kasper S; Kagawa S; Fang B; Matusik RJ; Denner L; Marcelli M
    J Natl Cancer Inst; 2001 Sep; 93(17):1314-24. PubMed ID: 11535706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
    Zhang W; Huang J; Tang Y; Yang Y; Hu H
    Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation
    Chen J; Zhang F; Ren X; Wang Y; Huang W; Zhang J; Cui Y
    Cancer Biol Med; 2020 Aug; 17(3):740-752. PubMed ID: 32944403
    [No Abstract]   [Full Text] [Related]  

  • 20. Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study.
    Sun A; Tang J; Terranova PF; Zhang X; Thrasher JB; Li B
    Int J Cancer; 2010 Feb; 126(3):764-74. PubMed ID: 19642108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.